Back to Articles
Spravato2024
Spravato (Esketamine) Nasal Spray: Long-Term Outcomes
The Lancet Psychiatry
Long-term follow-up data from Spravato clinical trials showing sustained benefits in treatment-resistant depression patients.
Interested in these treatments?
Schedule a free informational call to learn how Waybridge can help.
Get in Touch